← Open Payments lookup

WILMER MOUNGER: Open Payments

NPI 1396391942 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 33 payments from 14 companies in 2025. Trend: 2023 $38 · 2024 $263 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$151
Incyte Corporation5$111
Merck Sharp & Dohme LLC4$95
Eisai Inc.4$82
Genmab U.S., Inc.2$58
Genentech USA, Inc.2$49
Regeneron Healthcare Solutions, Inc.2$39
Rigel Pharmaceuticals, Inc.2$32
Pharmacosmos Therapeutics Inc.1$30
Janssen Biotech, Inc.1$27

Products named: KEYTRUDA, JAKAFI, Lenvima, ENHERTU, Epkinly, CARVYKTI, LIBTAYO, TAVALISSE.

Industry payments across TX — which companies pay providers there.